Matches in Nanopublications for { ?s ?p "[Compensatory activation of related ERBB family receptors (ERBB2 and ERBB3) was observed in GBM CSCs deprived of EGFR signal (EGF deprivation or cetuximab inhibition), suggesting an intrinsic GBM resistance mechanism for EGFR-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP163795.RAA9tlyKP9vVWHDDIlINR31WogVcBIlTg3M2g_UXUJ6pg130_assertion description "[Compensatory activation of related ERBB family receptors (ERBB2 and ERBB3) was observed in GBM CSCs deprived of EGFR signal (EGF deprivation or cetuximab inhibition), suggesting an intrinsic GBM resistance mechanism for EGFR-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163795.RAA9tlyKP9vVWHDDIlINR31WogVcBIlTg3M2g_UXUJ6pg130_provenance.
- assertion description "[Compensatory activation of related ERBB family receptors (ERBB2 and ERBB3) was observed in GBM CSCs deprived of EGFR signal (EGF deprivation or cetuximab inhibition), suggesting an intrinsic GBM resistance mechanism for EGFR-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP994009.RAp_aPmVP_qrIZRHX5AU6CBU_cs2r9tetZNAfwS_UyhU4130_assertion description "[Compensatory activation of related ERBB family receptors (ERBB2 and ERBB3) was observed in GBM CSCs deprived of EGFR signal (EGF deprivation or cetuximab inhibition), suggesting an intrinsic GBM resistance mechanism for EGFR-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994009.RAp_aPmVP_qrIZRHX5AU6CBU_cs2r9tetZNAfwS_UyhU4130_provenance.